MOKAN Wealth Management Inc.

Position in JNJ — Johnson & Johnson

CIK 2053727 OVERLAND PARK, KS

Position in JNJ

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,491,311

+$486,663 QoQ

Shares Held

5,872

+42.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.78%

of 13F equity value

Holder Rank

#2,604

of 4,664 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 7% None 93%

Healthcare · as of Jun 30, 2026

MOKAN Wealth Management Inc. holds $20,473,093 across 6 Drug Manufacturers - General names. JNJ ranks #4 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	48,990	$6,295,215
2	ABBV	AbbVie Inc.	23,835	$5,997,839
3	LLY	ELI LILLY & Co	4,208	$5,047,201
4	JNJ	Johnson & Johnson This page	5,872	$1,491,311
5	GILD	Gilead Sciences, Inc.	10,399	$1,313,809
6	AMGN	Amgen Inc	905	$327,718

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,491,311	5,872	+42.9%	Shares	Sole	2026-07-28
2026-03-31	$1,004,648	4,110	-60.6%	Shares	Sole	2026-05-01
2025-12-31	$2,158,695	10,431	-16.3%	Shares	Sole	2026-01-26
2025-09-30	$2,311,445	12,466	-11.7%	Shares	Sole	2025-10-30
2025-06-30	$2,156,066	14,115	+19.0%	Shares	Sole	2025-07-25
2025-03-31	$1,967,691	11,865	-1.3%	Shares	Sole	2025-04-23
2024-12-31	$1,739,200	12,026	—	Shares	Sole	2025-01-30
No filing history on record for this holder in this stock.